Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agents.
about
Targeting SQSTM1/p62 induces cargo loading failure and converts autophagy to apoptosis via NBK/Bik.Soft tissue sarcoma cells are highly sensitive to AKT blockade: a role for p53-independent up-regulation of GADD45 alpha.Effects of an Indolocarbazole-Derived CDK4 Inhibitor on Breast Cancer CellsCell cycle activation and spinal cord injury.Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2Identification of kinase inhibitors that target transcription initiation by RNA polymerase IIStatins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activationDelayed cell cycle pathway modulation facilitates recovery after spinal cord injuryUse of ATP analogs to inhibit HIV-1 transcription.Transcriptional upregulation of p57 (Kip2) by the cyclin-dependent kinase inhibitor BMS-387032 is E2F dependent and serves as a negative feedback loop limiting cytotoxicityEffects of Auraptene on IGF-1 Stimulated Cell Cycle Progression in the Human Breast Cancer Cell Line, MCF-7.Multifunctional drug treatment in neurotrauma.Natural Compounds as Modulators of Cell Cycle Arrest: Application for Anticancer Chemotherapies.Development of hemiasterlin derivatives as potential anticancer agents that inhibit tubulin polymerization and synergize with a stilbene tubulin inhibitor.A small molecule based on the pRb2/p130 spacer domain leads to inhibition of cdk2 activity, cell cycle arrest and tumor growth reduction in vivo.
P2860
Q34056627-094BDF5D-022C-4FC7-9959-11487F5CD3ABQ34240979-172F6A6B-CFCD-47F3-8ADE-435DEB545A46Q34487091-0F5ACF28-B408-4FD4-B204-76FD23B1ECA4Q35006482-9D5D09A4-1076-4475-9F3B-FF408FF278C1Q35220766-46F6C1B2-9D33-47F0-A018-43591A9EE6C2Q35640132-0B527529-037A-4CD9-92DE-4AFE8F088069Q35828643-B9E8D446-4D70-4E5E-A8D0-EFAB5ACE4670Q36023712-F923D2B2-F677-479B-8790-F2CA71DDFE18Q36202709-989C9230-7E78-4362-8B40-566EF165A171Q36247797-D37BBE20-B7FC-46EF-91AA-333EBE372335Q36505765-525B3C1E-010D-4238-B799-D5D7BAFC07D7Q37358650-2E069770-3C24-4F8D-8330-4C5F0842B8EDQ39214217-1AFA7FC2-21E2-47A8-BCE2-1DAAED52218FQ39528191-457A77AF-60CF-4F10-A2AC-82C46A321DC2Q40219887-219B0B28-AA18-4C76-AC05-21B80D7C1295
P2860
Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agents.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agents.
@ast
Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agents.
@en
type
label
Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agents.
@ast
Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agents.
@en
prefLabel
Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agents.
@ast
Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agents.
@en
P2860
P1476
Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agents.
@en
P2093
P2860
P2888
P304
P356
10.1007/S11912-004-0024-3
P577
2004-03-01T00:00:00Z